What is CBG?

Cannabigerol (CBG), is a cannabinoid that exists in the cannabis plant alongside more well-known counterparts like THC and CBD. It acts as a precursor to other cannabinoids, starting as CBGa, the “a” indicates the acid form before enzymatic processes convert it into compounds such as THC, CBD, CBC, and CBG.

CBG, one of the numerous cannabinoids present in the cannabis plant, is gaining attention for its distinct properties and potential therapeutic applications. While cannabinoids like THC and CBD have been extensively studied, CBG, often considered a minor cannabinoid due to its lower concentrations, holds promise as a novel player in the world of medicinal cannabis.

CBG in Cannabis Plants:

Typically found in lower concentrations in mature cannabis plants, CBGa undergoes conversion into other cannabinoids as the plant matures. Researchers are exploring selective breeding and genetic manipulation techniques to develop cannabis strains with higher CBG content.

Potential Therapeutic Benefits:

1. Anti-Inflammatory Properties: CBG exhibits promising anti-inflammatory effects, as demonstrated in a 2013 study published in the Biological and Pharmaceutical Bulletin. In a mouse model of inflammatory bowel disease, CBG showcased significant anti-inflammatory properties, suggesting potential applications in conditions characterized by inflammation.
2. Neuroprotective Effects: Studies indicate that CBG may possess neuroprotective properties, making it a potential candidate for treating neurodegenerative diseases. A 2015 study published in the Journal of Neurochemistry found that CBG protected neurons in a cellular model of Huntington’s disease, a progressive neurodegenerative disorder.
3. Antibacterial and Antifungal Activity: CBG’s antibacterial and antifungal properties have been explored in various studies. Research published in the Journal of Natural Products in 2008 revealed CBG’s effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), showcasing potential in developing new antimicrobial agents.
4. Appetite Stimulation: CBG, like THC, has demonstrated appetite-stimulating effects. This property could be beneficial for individuals undergoing treatments that suppress appetite or for those with conditions like cachexia.
5. Glaucoma Management: CBG has been investigated for its potential in managing glaucoma, a condition characterized by increased intraocular pressure. A study published in the Journal of Ocular Pharmacology and Therapeutics in 2008 found that CBG, along with other cannabinoids, could reduce intraocular pressure in a dose-dependent manner.

Conclusion:

Cannabigerol (CBG) stands out as a cannabinoid with diverse potential therapeutic benefits. From its anti-inflammatory and neuroprotective properties to its antibacterial and appetite-stimulating effects, CBG presents a range of possibilities for medical applications.

As the scientific community continues to explore CBG, it could potentially emerge as a valuable component of medical cannabis formulations, contributing to the expanding repertoire of cannabinoids available for therapeutic use.

References

1. Pagano, E., Montanaro, V., Di Girolamo, A., & Pistone, A. (2015). Cannabigerol exposure alters the expression of miRNAs in keratinocytes. Experimental Dermatology, 24(7), 567–572.
2. Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Battista, G., Pagano, E., Di Marzo, V., & Izzo, A. A. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochemical Pharmacology, 85(9), 1306–1316.
3. Valdeolivas, S., Navarrete, C., Cantarero, I., Bellido, M. L., & Muñoz, E. (2015). Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. Journal of Neurochemistry, 134(6), 956–969.
4. Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., Smith, E., & Rahman, M. M. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. Journal of Natural Products, 71(8), 1427–1430.
5. Colasanti, B. K. R., Lindamood, C., & Craig, C. R. (1984). Effects of cannabinoids on aqueous humor dynamics and ciliary body permeability in rabbits. Journal of Ocular Pharmacology and Therapeutics.

#beautiful #cbd #cbdbenefits #cbdforacne #cbdforhair #cbdforhealth #cbdfortheface #cbdfortheskin #cbdhealing #skincare #skincareaddict #skincareaddition #skincareblog #skincarecommunity #skincarejunkie #skincarelove #skincaremakeup #skincareproducts #skincareroutine #cbg #cbc #cannabinoids #ecs #endocannabinoidsystem